Eximo Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$60.7M
Eximo General Information
Description
Provider of a hybrid catheter technology designed to offer tissue resection invascular and gastrointestinal endoluminal applications. The company's technology offers optical fibers that deliver short laser pulse and a blunt mechanical knife, enabling doctors to optimize safety and performance during atherectomy procedures to reduce the risk of vessel perforation in patients.
Contact Information
Website
www.eximomedical.comCorporate Office
- 3 Pekeris street
- Einstein building Floor Number 1, Tamar Park
- Rehovot 7670203
- Israel
Corporate Office
- 3 Pekeris street
- Einstein building Floor Number 1, Tamar Park
- Rehovot 7670203
- Israel
Eximo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 02-Oct-2019 | $60.7M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 06-Jun-2016 | Completed | Startup | |||
| 2. Early Stage VC | 16-Aug-2012 | $400K | $400K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Eximo Comparisons
Industry
Financing
Details
Eximo Competitors (16)
One of Eximo’s 16 competitors is Alvimedica, a Corporation company based in Istanbul, Turkey.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alvimedica | Corporation | Istanbul, Turkey | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Masimo | Formerly PE-Backed | Irvine, CA | ||||
| Cagent Vascular | Venture Capital-Backed | Wayne, PA | ||||
| Endologix | Corporation | Santa Rosa, CA |
Eximo Patents
Eximo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12038322-B2 | Devices and methods for testing ablation systems | Active | 21-Jun-2022 | ||
| US-20230408329-A1 | Devices and methods for testing ablation systems | Active | 21-Jun-2022 | ||
| US-20240393171-A1 | Devices and methods for testing ablation systems | Pending | 21-Jun-2022 | ||
| EP-4433111-A1 | Smart aspiration system | Pending | 16-Nov-2021 | ||
| US-20230149033-A1 | Smart aspiration system | Pending | 16-Nov-2021 | A61M1/742 |
Eximo Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accel | Venture Capital | Minority | ||
| Accelmed | Growth/Expansion | Minority | ||
| Arkin Capital | Asset Manager | Minority | ||
| Incentive Incubator | Accelerator/Incubator | Minority | ||
| Peregrine Ventures | Venture Capital | Minority |
Eximo FAQs
-
When was Eximo founded?
Eximo was founded in 2012.
-
Where is Eximo headquartered?
Eximo is headquartered in Rehovot, Israel.
-
What industry is Eximo in?
Eximo’s primary industry is Therapeutic Devices.
-
Is Eximo a private or public company?
Eximo is a Private company.
-
What is the current valuation of Eximo?
The current valuation of Eximo is .
-
What is Eximo’s current revenue?
The current revenue for Eximo is .
-
How much funding has Eximo raised over time?
Eximo has raised $2M.
-
Who are Eximo’s investors?
Accel, Accelmed, Arkin Capital, Incentive Incubator, and Peregrine Ventures are 5 of 8 investors who have invested in Eximo.
-
Who are Eximo’s competitors?
Alvimedica, Spine Wave, Masimo, Cagent Vascular, and Endologix are some of the 16 competitors of Eximo.
-
When was Eximo acquired?
Eximo was acquired on 02-Oct-2019.
-
Who acquired Eximo?
Eximo was acquired by Angiodynamics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process